Journals / Türk Oftalmoloji Dergisi / 2003 / Cilt: 33 - Sayı: 3

Risk factors effecting the visual outcomes of grid laser photocoagulation in patients with diffuse diabetic macular edema

Diffüz diyabetik maküla ödemli olgularda grid laser fotokoagülasyon sonrası görsel sonuçları etkileyen risk faktörleri

Pages
394–400
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Additional studies with more patients are required to determine more accurately the risk factors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To determine the risk factors effecting the visual outcomes of argon grid laser photocoagulation in patients with diffuse diabetic macular edema.Methods: 202 eyes of 148 patients with diffuse diabetic macular edema who underwent argon grid laser photocoagulation were retrospectively analyzed.
📊
Key Findings & Data:Results: As analyzed by multiple logistic regression model, type of diabetes treatment was found to be the statistically significant risk factor for the poor visual outcomes of grid laser photocoagulation (p0,05).
💡
Conclusion & Impact:Additional studies with more patients are required to determine more accurately the risk factors.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To determine the risk factors effecting the visual outcomes of argon grid laser photocoagulation in patients with diffuse diabetic macular edema.Methods: 202 eyes of 148 patients with diffuse diabetic macular edema who underwent argon grid laser photocoagulation were retrospectively analyzed. Age, gender, age at the onset of diabetes, duration of diabetes, type of diabetes treatment, type of diabetes, stage of diabetic retinopathy, number of grid laser treatment, cataract operation, panretinal photocoagulation (PRP) and presence of hypertension (HT) were the factors, which were evaluated for their effects on the visual outcomes of grid laser photocoagulation. The multivariate-adjusted association between these factors and visual acuity changes after grid laser photocoagulation was evaluated with logistic regression analysis. On the other hand, Chi-square test was used to investigate the independent effects of these factors on the visual outcomes. Results: As analyzed by multiple logistic regression model, type of diabetes treatment was found to be the statistically significant risk factor for the poor visual outcomes of grid laser photocoagulation (p0,05). When the factors were investigated independently, none of these factors had a statistically significant effect on the visual outcomes of grid laser photocoagulation (p>0,05). Conclusion: Age, gender, age at the onset of diabetes, duration of diabetes, type of diabetes, stage of diabetic retinopathy, type of diabetes treatment, number of grid laser treatment, ca-taract operation, PRP and HT were observed to have no significant independent effect on the vi-sual outcomes of argon grid laser photocoagulation. Additional studies with more patients are required to determine more accurately the risk factors.

Özet

Amaç: Diffüz diyabetik maküla ödemli olgularda argon grid laser fotokoagülasyon sonrası görsel sonuçları etkileyen risk faktörlerini belirlemek Yöntem: Diffüz diyabetik maküla ödemi tanısıyla grid laser fotokoagülasyon yapılan 148 diyabetik hastanın 202 gözü retrospektif olarak incelendi. Grid laser fotokoagülasyon sonrası görme keskinliği üzerine etkileri araştırılan faktörler yaş, cinsiyet, diyabetin başlangıç yaşı, diyabet süresi, diyabetin tedavi şekli, diyabetin tipi, hipertansiyon (HT), diyabetik retinopati düzeyi, katarakt ameliyatı, panretinal fotokoagülasyon (PRF) ve grid laser seans sayısı idi. Grid laser fotokoagülasyon sonrası görme keskinliği değişikliği ile bu faktörler arasındaki çok değişkenli ilişki lojistik regresyon analizi ile değerlendirildi. Öte yandan, faktörlerin birbirinden ba-ğımsız olarak görme keskinliği üzerine etkilerinin incelenmesinde Ki-kare testi kullanıldı. Bulgular: Lojistik regresyon analizinde, grid laser fotokoagülasyon sonrası kötü görsel sonuç için istatistiksel olarak anlamlı risk faktörünün, diyabetin tedavi şekli olduğu bulunurken (p0,05). Faktörler birbirinden bağımsız incelendiğinde ise, bu faktörlerden hiçbirinin grid laser fokoagülasyon sonrası görsel sonuçlara istatistiksel olarak anlamlı bir etkisinin olmadığı görüldü (p>0,05). Tartışma: Yaş, cinsiyet, ilaçla kontrol altına alınan HT, diyabetin başlangıç yaşı, diyabet süresi, diyabetin tipi, diyabetin tedavi şekli, diyabetik retinopati düzeyi, katarakt ameliyatı, PRF ve grid laser fotokoagülasyon seans sayısının birbirinden bağımsız olarak grid laser fotokoagülasyon sonrası görsel sonuçlara anlamlı bir etkisinin olmadığı görüldü. Grid laser fotokoagülasyon sonrası görsel sonuçlara etkili risk faktörlerinin daha sağlıklı olarak belirlenebilmesi için, daha çok sayıda olgu içeren çalışmaların yapılması gerekmektedir.

🔖

Cite This Article

YANYALI, A., ÖZMEN, D., KARAAĞAÇ, H., BAYRAK, Y., NOHUTÇU, A. F. (2022). Risk factors effecting the visual outcomes of grid laser photocoagulation in patients with diffuse diabetic macular edema. Türk Oftalmoloji Dergisi, Cilt: 33 - Sayı: 3, 394–400. https://ajindex.com/articles/638998

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. McMeel JW, Trempe CL, Franks EB: Diabetic maculo- pathy. Trans Am Acad Ophthalmol Otolaryngol 1977; 83: 476-85
  2. Patz A, Fine SL: Observations in diabetic macular edema. In: Symposium on Retinal Diseases: Transactions of the New Orleans Academy of Ophthalmology. St Louis: CV Mosby, 1977; 112
  3. Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report num- ber 4. Int Ophthalmol Clin 1987; 27: 265-72 4. Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report num- ber 1. Arch Ophthalmol 1985; 103: 1796-806 5. Olk RJ: Modified grid argon (blue-green) laser photocoa- gulation for diffuse diabetic macular edema. Ophthalmo- logy 1986; 93:938-50 6. Early Treatment Diabetic Retinopathy Study Research Group: Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Tre- atment Diabetic Retinopathy Study report number 2. Ophthalmology 1987; 94: 761-74 7. Wallow IH: Repair of the pigment epithelial barrier follo- wing photocoagulation. Arch Ophthalmol 1984; 102: 126-35 8. Arsan AK, Beştaş H, Sargın M: Diyabetik maküla öde- minde modifiye grid fotokoagülasyon uzun dönem görme keskinliği sonuçlan. Oftalmoloji 1998; 5: 369-72 9. Lee CM, Olk RJ: Modified grid argon laser photocoagu- lation for diffuse diabetic macular edema. Ophthalmology 1991; 98: 1594-602 10. Çeliker Ü, Esmergil S, Çelebi S, Kükner Ş: Diabetik ma- külopatide fotokoagülasyon sonrası görsel sonuçlarımız. Ret-Vit 1995; 3: 384-87 11. Taner P, Akarsu C, Ergin A, Vural E: Diabetik makülopa- tide argon lazer fokal ve grid fotokoagülasyon sonrası görsel sonuçlarımız ve tedavinin başarısını etkileyen fak- törler. Ret-Vit 2001; 9: 232-239 12. Lee CM, Oik RJ, Akduman L: Combined modified grid and panretinal photocoagulation for diffuse diabetic ma- cular edema and proliferative diabetic retinopathy. Oph- thalmic Surg Lasers 2000; 31: 292-300 13. Jaffe GJ, Burton TC: Progression of nonproliferative dia- betic retinopathy following cataract extraction. Arch Ophthmol 1988; 106: 745-49 14. Schatz H, Atienze D, McDonald R, Johnson RN: Severe diabetic retinopathy after cataract surgery. Am J Ophthal- mol 1994; 117:314-21 15. Straatsma BR, Petit TE, Wheeler N, Miyamasu M: Diabe- tes mellitus and intraocular lens implantation. Ophthal- mology 1983; 90: 336-43 16. Akduman L, Oik RJ: La